NCT07155980View on ClinicalTrials.gov

A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 9, 2025

Primary Completion Date

June 11, 2026

Study Completion Date

June 11, 2026

Conditions
Healthy Adult Participants
Interventions
DRUG

GSM-779690T

Opaque capsules for oral consumption.

OTHER

Placebo

Opaque capsules for oral consumption.

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

Sponsors
All Listed Sponsors
lead

Acta Pharmaceuticals, Inc

INDUSTRY